XT
AVXL icon

XTX Topco’s Anavex Life Sciences AVXL Stock Holding History

XTX Topco’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$792K Buy
258,071
+159,013
+161% +$689K 0.01% 1623
2025
Q4 		$353K Buy
99,058
+17,356
+21% +$106K 0.01% 1931
2025
Q3 		$727K Buy
+81,702
New +$829K 0.04% 793
2025
Q1 		– Sell
-52,344
Closed -$562K – 2409
2024
Q4 		$562K Buy
+52,344
New +$403K 0.05% 673
2023
Q3 		– Sell
-21,423
Closed -$174K – 1557
2023
Q2 		$174K Buy
21,423
+8,212
+62% +$70.4K 0.03% 1052
2023
Q1 		$113K Sell
13,211
-25,076
-65% -$250K 0.02% 1077
2022
Q4 		$355K Buy
+38,287
New +$409K 0.08% 480

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

XTX Topco's AVXL Position: Q1 2026 in Review

XTX Topco increased its Anavex Life Sciences (AVXL) stake by 161% in Q1 2026, buying an estimated $689K and bringing the position to 258,071 shares worth $792K. The position accounts for 0.01% of the portfolio, ranked #1623.

XTX Topco first reported a position in AVXL in Q4 2022 and has held it in 7 quarters since. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • XTX Topco held 258,071 shares of Anavex Life Sciences worth $792K as of Q1 2026.
  • XTX Topco bought 159,013 Anavex Life Sciences shares in Q1 2026, an estimated $689K.
  • Anavex Life Sciences made up 0.01% of XTX Topco's portfolio in Q1 2026, its #1623 holding.
  • XTX Topco first reported a position in Anavex Life Sciences in Q4 2022 and has held it in 7 quarters since.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.